General Information
Drug ID
DR00290
Drug Name
Lopinavir
Synonyms
A 157378; A 157378.0; A-157378-0; A-157378.0; ABT 157378; ABT 378; ABT-378; ABT-378, LOPINAVIR; AIDS032937; Aluvia (TN); Aluviran; Kaletra (TN); Koletra; LPV; Lopinavir (JAN/USAN/INN); Lopinavir [USAN:INN:BAN]; RS-346
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD11: 1C62.Z] Approved [1]
Therapeutic Class
Anti-HIV Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=92727"></iframe>
3D MOL 2D MOL
Formula
C37H48N4O5
Canonical SMILES
CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=<br />C3)NC(=O)C(C(C)C)N4CCCNC4=O)O
InChI
InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1
InChIKey
KJHKTHWMRKYKJE-SUGCFTRWSA-N
CAS Number
CAS 192725-17-0
Pharmaceutical Properties Molecular Weight 628.814 Topological Polar Surface Area 120
Heavy Atom Count 46 Rotatable Bond Count 15
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 5
PubChem CID
92727
PubChem SID
10225535 , 103198077 , 104178992 , 104408196 , 11108093 , 11528784 , 123080504 , 124757206 , 124893167 , 125164010 , 126522368 , 126655919 , 126665841 , 127310211 , 127310212 , 127310213 , 127338643 , 127338644 , 127338645 , 134337997 , 135051036 , 136283935 , 136367896 , 14912304 , 14912305 , 26737285 , 26757998 , 44423527 , 46392556 , 46508588 , 49853992 , 50086984 , 50096471 , 50096475 , 50111692 , 53812811 , 53812974 , 56310583 , 57335304 , 583260 , 615079 , 76999753 , 7848488 , 7885634 , 7979791 , 826916 , 841952 , 87557375 , 87557376 , 99437252
ChEBI ID
ChEBI:31781
TTD Drug ID
D0U5GB
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
MRP1 Transporter Info Multidrug resistance-associated protein 1 Substrate [3]
MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [4]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [5]
P-GP Transporter Info P-glycoprotein 1 Substrate [4]
References
1 Lopinavir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64.
3 Inhibition of P-glycoprotein and multidrug resistance-associated proteins modulates the intracellular concentration of lopinavir in cultured CD4 T cells and primary human lymphocytes. J Antimicrob Chemother. 2007 Nov;60(5):987-93.
4 Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir. Br J Pharmacol. 2010 Jul;160(5):1224-33.
5 Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.